Serial Number | 76203580 |
Word Mark | ARIALTA |
Filing Date | Thursday, February 1, 2001 |
Status | 604 - ABANDONED - AFTER INTER-PARTES DECISION |
Status Date | Wednesday, May 1, 2002 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, August 21, 2001 |
Goods and Services | PHARMACEUTICAL PREPARATIONS, FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CENTRAL NERVOUS SYSTEM DISEASES, CANCER, INFLAMMATION AND INFLAMMATORY DISEASES, RESPIRATORY AND INFECTIOUS DISEASES AND FOR DIAGNOSTIC IMAGING |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 8 - Abandoned |
Class Status Date | Monday, May 6, 2002 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | DuPont Pharmaceuticals Company |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 02 - Partnership |
Address | Wilmington, DE 19805 |
Party Name | DuPont Pharmaceuticals Company |
Party Type | 10 - Original Applicant |
Legal Entity Type | 02 - Partnership |
Address | Wilmington, DE 19805 |
Event Date | Event Description |
Wednesday, May 1, 2002 | ABANDONMENT - AFTER INTER PARTES DECISION |
Wednesday, May 1, 2002 | OPPOSITION TERMINATED NO. 999999 |
Wednesday, May 1, 2002 | OPPOSITION SUSTAINED NO. 999999 |
Wednesday, January 16, 2002 | OPPOSITION INSTITUTED NO. 999999 |
Wednesday, October 3, 2001 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Tuesday, August 21, 2001 | PUBLISHED FOR OPPOSITION |
Wednesday, August 1, 2001 | NOTICE OF PUBLICATION |
Monday, June 4, 2001 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 23, 2001 | ASSIGNED TO EXAMINER |